Six new drug discovery acceleration projects supported by CQDM and Ontario Centres of Excellence showcase continued success of Quebec-Ontario Life Sciences Corridor

SAN FRANCISCO, June 7, 2016 /CNW/ - Partners since 2012, CQDM and Ontario Centres of Excellence (OCE) are pleased to announce the funding of six new game-changing research projects to accelerate drug discovery under the Quebec-Ontario Life Sciences Corridor, for a total of $1.8M invested. The projects are part of the Explore program and were announced at the 2016 BIO International Convention in San Francisco which was attended by Dominique Anglade, Quebec's Minister of Economy, Science and Innovation and Minister responsible for the Digital Strategy.

The unique CQDM/OCE Explore program funds Quebec and Ontario-based researchers whose unconventional research projects provide early concept validation of cutting-edge technologies that address the needs of biopharmaceutical research. CQDM's pharmaceutical members are particularly involved in this program. Senior scientists from member companies provide industrial expertise and support to the funded projects through CQDM's mentoring program.

The six projects will focus on innovative approaches to treating cancer and heart diseases as well as new vaccine therapies and other drug discovery. The project teams will be led by Dr. Robert Batey (University of Toronto), Dr. Mickie Bhatia and Dr. Michael Thompson (McMaster University), Dr. Yves St-Pierre (INRS – Institut Armand-Frappier), Dr. Daniel Larocque (PAIRimmune Inc.) and Dr. Jason Maynes (Hospital for Sick Children).

Through the Quebec-Ontario Life Sciences Corridor, immense strides have been made by the two provinces in Canadian scientific R&D. Today's announcement brings to 15 the number of projects co-funded between CQDM and OCE. These funded projects are comprised of 39 researchers from 18 public and private organizations who are committed to accelerating innovation in the drug discovery and development processes.

This whole-of-government approach to funding innovation, including federal government support, creates an efficient means for industry to access academic expertise and resources.

"We are delighted about our long-lasting partnership with OCE. Together, under the Quebec-Ontario corridor, we fund the best possible research in our two provinces. Our strong inter-provincial collaboration fortifies the Canadian life sciences ecosystem and makes the co-funding of these unique and very innovative projects possible. We have pulled our strengths and resources together to build strong research networks in Quebec and Ontario," said Dr. Diane Gosselin, President and CEO of CQDM.

"We are very pleased to be working in partnership with CQDM with the shared goal of enhancing the capacity of our two provinces to commercialize research and increase global competitiveness in the important area of drug discovery," said Dr. Tom Corr, President and CEO of Ontario Centres of Excellence. "This is an excellent program that enables researchers to undertake unconventional research that challenges established practices in the drug R&D process and has the potential to transform current models and ways of thinking."

"Through these research projects, Québec and Ontario are once again joining forces to further foster drug discoveries that will enhance the quality of life of many Quebecers and Canadians. I would like to pay tribute to CQDM's outstanding contribution to the establishment of the partnerships, which are further bolstering Québec's expertise in the life sciences industry," Minister of Economy, Science and Innovation and Minister responsible for the Digital Strategy Dominique Anglade noted.

"I am excited about these six new projects, which will accelerate groundbreaking discoveries and strengthen our innovation ecosystem. I am grateful to both OCE and CQDM for their sustained efforts to foster collaboration between Ontario and Quebec." said Reza Moridi, Ontario's Minister of Research and Innovation. "Both provinces have ever-expanding life sciences sectors, and a lot to offer each other, including knowledge and expertise that can shape an enhanced tomorrow. By working together, we remain focused on the future, and committed to driving discoveries that change people's lives."

More information on the six projects is available on the OCE website.

Une version française de ce communiqué de presse est également disponible.

About CQDM
CQDM is a pharma-based consortium active in early research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM's business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research and benefit from its results. CQDM also provides a common meeting ground where academia, governments, and the pharmaceutical and biotechnology industries converge to address numerous complex medical challenges. CQDM receives financial support from Merck, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Eli Lilly Canada, Janssen, Novartis Pharma Canada, Sanofi Canada, as well as from Quebec's Ministry of Economy, Science and Innovation (MESI) and from the Government of Canada under the Business-Led Networks of Centres of Excellence Program (BL-NCE). For more information: www.cqdm.org.

About the Ontario Centres of Excellence (OCE)
Ontario Centres of Excellence (OCE) drives the commercialization of cutting-edge research across key market sectors to build the economy of tomorrow and secure Ontario's global competitiveness. In doing this, OCE fosters the training and development of the next generation of innovators and entrepreneurs and is a key partner with Ontario's industry, universities, colleges, research hospitals, investors and government ministries. A champion of leading-edge technologies, best practices and research, OCE invests in sectors such as advanced health, information and communications technology, digital media, advanced materials and manufacturing, agri-food, aerospace, transportation, energy, and the environment including water and mining.  Funded by the Government of Ontario, OCE is a key partner in delivering Ontario's Innovation Agenda as a member of the province's Ontario Network of Entrepreneurs (ONE). For more information: http://www.oce-ontario.org.

SOURCE Ontario Centres of Excellence Inc.

For further information: Eugénie Bergeron-Côté, Communications Advisor, CQDM, Tel.: (514) 766-6661, ext. 2196, ebergeron@cqdm.org; Stuart Green, Manager, Media Relations, Ontario Centres of Excellence, Tel.: (416) 861-1092, ext. 1022, stuart.green@oce-ontario.org

RELATED LINKS
http://www.oce-ontario.org/

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890